OXGR1

Across TCGA pan-cancer cohorts, OXGR1 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated OXGR1 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher OXGR1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated OXGR1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

BRCA, BLCA, and LUSC are the cancer types where OXGR1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	All	0.094	0.578	.002	30	view →
BLCA	OS	Median	All	0.183	0.618	.008	30	view →
LUSC	OS	Median	II,III,IV	0.147	0.743	.002	30	view →
UCEC	DFS	Median	All	1.000	0.633	.021	26	view →
HNSC	DFS	Median	II,III,IV	0.101	0.695	<.001	24	view →
MESO	DFS	Median	II,III,IV	0.039	0.407	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

OXGR1–BRCA (OS)

Open the BRCA breakdown →